Lowe Syndrome Association

Latest from Lowe Syndrome Association

Amid Drug Shortage, FDA Approves Generic Valsartan

March 13, 2019


Recalls on Diovan (valsartan) began last July when the FDA detected trace amounts of a probable carcinogen in certain lots of the blood pressure drug.

AFX Endovascular AAA Systems Recalled by Endologix, Inc. for Risk of Type III Endoleaks

October 20, 2018


Not sure what’s been recalled, withdrawn from the market, or had safety updates? Catch up on the US Food and Drug Administration’s (FDA's) recalls and safety news from this past week.

Opioids + Comorbidities = Trouble?

June 29, 2016


The increase in opioid prescribing for non-cancer pain has drawn attention to the corresponding increase in unintentional overdose deaths.

First Hypertension Drug of Its Kind Obtains FDA Approval

June 07, 2016


The combination of nebivolol/valsartan (Byvalson) lowers blood pressure better than either drug by themselves.

Epilepsy Drug May Protect Against Optic Neuritis in Multiple Sclerosis

March 04, 2016


The anticonvulsant drug phenytoin may protect neural tissue in patients with optic neuritis, a common symptom of multiple sclerosis.

Patients with Epilepsy Being Treated with Oxcarbazepine Should Have Their Serum Sodium Levels Carefully Monitored

February 28, 2014


Researchers identify several independent risk factors for the development of severe and/or symptomatic hyponatremia in patients on oxcarbazepine therapy.